Allergy Clinic Supply Checklist

An allergy and immunotherapy practice carries an anaphylaxis risk profile that most outpatient specialties don’t share at the same frequency, because the two things allergists do most often — skin prick/intradermal testing with diluted allergen extracts and subcutaneous immunotherapy injections — are deliberately designed to provoke a measurable allergic response. A well-run practice treats that as a known, planned-for risk rather than a rare event: emergency-response supplies are staged at the point of injection, not stored in a back room, and the practice’s stocking list reflects that.

This checklist covers what a genuine allergy/immunotherapy office needs to stock across skin-test-site preparation, immunotherapy administration, and anaphylaxis emergency-response readiness, plus the staffed observation-period infrastructure that allergy/immunology practice parameters call for after allergen injections. It does not cover general outpatient clinic build-out, which CASRAI’s clinic startup equipment checklist already covers.

Where to source this: LAC (lac.us) — CASRAI’s sister medical-supply business — stocks the three categories this checklist leans on most directly. Its alcohol prep pads category covers skin-test-site and injection-site prep supplies; its first aid kits category covers emergency-kit containers and refill supplies for the anaphylaxis cart; and its AEDs & defibrillators category covers the AED unit and replacement pads/battery a practice’s emergency-response cart should include.

Why allergy/immunotherapy practices carry a distinct anaphylaxis risk

Allergen challenge testing and allergen immunotherapy both work by exposing a sensitized patient to a controlled dose of the substance they’re allergic to — that’s the entire diagnostic and therapeutic mechanism. Most exposures produce only the intended local or measurable response. A small but real fraction produce a systemic reaction, and immunotherapy injections in particular carry a recognized, if low, risk of anaphylaxis, including reactions that begin after the patient has technically finished the visit. That risk profile is why allergy/immunology is one of the few outpatient specialties where anaphylaxis-response readiness is a routine, planned-for part of daily operations rather than a rare-event contingency bolted on after the fact.

Two supply categories follow directly from that risk profile: what the practice stocks to prepare and administer testing/injections safely, and what it stocks to recognize and treat a reaction immediately if one occurs. Both are covered below, along with the observation-period infrastructure that connects them.

Skin-test-site and injection-site preparation supplies

Skin prick testing, intradermal testing, and immunotherapy injections all begin with the same basic requirement: a clean, properly prepped site and accurate placement of a measured dose.

• Alcohol prep pads — for cleansing the test site or injection site before each application; a high-volume consumable given how many individual test sites or injections a single visit can involve. See CASRAI’s skin antisepsis before injection guide for the general protocol and product-selection considerations that apply here.
• Skin-test devices/applicators — single-use multi-test or single-test prick/puncture devices, sized and graduated to the practice’s testing panel.
• Allergen extracts and diluents, including histamine (positive control) and diluent/saline (negative control) — controls are what let the practice interpret a wheal-and-flare result as a true positive rather than an artifact of technique or a non-reactive patient.
• Skin-marking pens and measuring calipers/rulers — for grading wheal size against the practice’s scoring convention.
• 1 mL syringes with fine-gauge needles — for intradermal testing and for drawing/administering immunotherapy injection doses from vials.
• Sharps containers at each testing/injection station, not just centrally, given the volume of single-use needles a busy allergy clinic goes through in a day.

Immunotherapy administration and dosing supplies

Subcutaneous immunotherapy (SCIT) is typically built up on a defined build-up/maintenance schedule from vials the practice compounds and stores per patient. That workflow adds its own stocking list on top of the testing supplies above:

• Patient-specific vial storage and a clear labeling/verification system — immunotherapy dosing errors are a recognized patient-safety risk specifically because doses escalate over a build-up schedule and multiple patients’ vials are stored together; a two-person or barcode-verified check before each injection is standard practice-parameter guidance, and the supply side of that is a labeling/storage system that supports it, not just a refrigerator shelf.
• Tourniquets — kept at the injection site specifically to slow systemic absorption if a reaction begins immediately after an injection, a documented first step in on-site anaphylaxis response for injected allergens.
• Insulin-style or tuberculin syringes in the gauge/volume the practice’s dosing protocol calls for.
• A dosing/build-up schedule reference and documentation system at the point of injection, so the administering staff member is verifying against the patient’s actual current dose, not relying on memory.

Anaphylaxis emergency-response readiness

This is the category that most distinguishes an allergy/immunotherapy practice’s stocking list from a general outpatient clinic’s. Emergency-response supplies belong at or immediately adjacent to the injection/testing area itself, staged and checked on a routine schedule, not stored centrally where retrieval time matters.

• Injectable epinephrine — the first-line, time-critical treatment for anaphylaxis; typically stocked as both auto-injectors (for speed and staff-training simplicity) and ampule/vial-plus-syringe (for dose flexibility, particularly in pediatric patients). See CASRAI’s dental office medical emergency supply checklist for a comparable critical/non-critical stocking framework built around epinephrine as the first-tier drug — the same logic applies here.
• Supplemental oxygen and delivery devices (nasal cannula, non-rebreather mask, bag-valve-mask) — airway compromise and hypoxia are core features of a severe reaction.
• IV access supplies and isotonic fluids — for practices whose protocol includes IV fluid support during a reaction, per their emergency-response plan and staff scope of practice.
• An AED — for the rare but real progression to cardiac involvement; see CASRAI’s emergency response cart checklist for outpatient clinics for how to organize an AED alongside the rest of a multi-category response cart.
• Antihistamines and corticosteroids (oral and injectable, per protocol) — second-line treatment for the histamine-mediated and delayed/biphasic components of a reaction.
• A documented, staff-drilled anaphylaxis response protocol posted at the point of care — the supply list only functions if staff know the sequence without having to look it up mid-reaction.

The post-injection observation period

Allergy/immunology practice-parameter guidance (the AAAAI-type consensus followed across the specialty) calls for a defined observation period after allergen immunotherapy injections and after allergen challenge testing, on the premise that most reactions serious enough to require treatment begin within a bounded window after administration rather than at unpredictable, much later times. Exact recommended windows vary by injection type and by patient risk factors and are set by the practice’s own protocol against current specialty guidance — the operational point for stocking purposes is that the observation period needs supporting infrastructure, not just a clock:

• A visible, staffed waiting area distinct from general patient waiting, so a staff member can observe for early signs of a reaction (hives, throat tightness, wheezing, dizziness) rather than relying on the patient to self-report.
• A timer or check-in system tied to each patient’s injection time, so the observation window is enforced consistently rather than left to informal judgment.
• Documentation supplies/EHR fields to record the observation outcome for each visit — this is also the record that supports informed dose adjustments on the patient’s next visit if a reaction did occur.
• Signage or a laminated patient-facing card describing delayed-reaction warning signs to watch for after leaving the office, since a smaller share of reactions can begin after the in-office observation window ends.

Cold chain and storage for allergen extracts and injectable medications

Allergen extracts and compounded immunotherapy vials are biologic products that lose potency outside their labeled storage range, and injectable epinephrine and other emergency medications carry their own storage and expiration requirements. A dedicated, monitored refrigerator — separate from any general-use unit, with a temperature log or continuous monitoring alarm and a documented process for what happens on an excursion — is standard practice, not an optional upgrade. See CASRAI’s cold chain dictionary entry for the general storage-integrity concept this stocking requirement is built on.

Staff training and protocol readiness

None of the supplies above function without trained staff who can retrieve and use them without hesitation. A recurring, drilled anaphylaxis-response protocol — covering who administers epinephrine, who calls emergency services, who manages the airway, and who documents the event — is what the supply list is actually in service of. Practices typically pair this with routine expiration-date checks on epinephrine and other time-sensitive stock, since an expired auto-injector at the moment it’s needed is functionally the same as not stocking one at all.

Frequently asked questions

Do allergy clinics need an AED?

Most allergy/immunotherapy practices stock one given the (rare but real) risk of a reaction progressing to cardiac involvement, and given that many operate as freestanding outpatient offices without on-site advanced life support. Exact requirements vary by state and by the practice’s own risk assessment — see CASRAI’s emergency response cart checklist for how an AED fits into a broader response-cart build.

How long should the post-injection observation period be?

Specialty practice-parameter guidance sets observation windows by injection type and patient risk, and a practice’s own protocol should track current AAAAI/ACAAI-aligned guidance rather than a fixed rule of thumb — the operational requirement covered in this guide is having the staffed area, timer/check-in system, and documentation to actually enforce whatever window the practice’s protocol specifies.

Why stock both epinephrine auto-injectors and ampule/vial-plus-syringe epinephrine?

Auto-injectors are fast and require minimal training to use correctly under stress, which matters when any trained staff member may need to respond. Ampule/vial-plus-syringe stock gives the practice dose flexibility — particularly useful for pediatric patients, where auto-injector fixed doses don’t always match the weight-based dose a clinician wants to give.

What’s different about immunotherapy vial storage compared to a general clinic refrigerator?

Immunotherapy vials are patient-specific, dose-escalating, and biologic — they need a labeling and verification system that prevents mix-ups between patients as much as they need correct temperature. A dedicated, monitored unit with a clear labeling protocol addresses both requirements; see the cold chain link above for the underlying storage-integrity principle.